Joseph Frattaroli
Keine laufenden Positionen mehr
Vermögen: 15 229 $ am 30.04.2024
Karriereverlauf von Joseph Frattaroli
Ehemalige bekannte Positionen von Joseph Frattaroli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.04.2018 | 31.03.2024 |
Vaso Active Pharmaceuticals, Inc.
 Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Finanzdirektor/CFO | 24.12.2009 | 06.11.2012 |
| Präsident | 01.06.2003 | 06.11.2012 | |
| Flagship Consulting, Inc. | Gründer | 01.01.2010 | - |
Ausbildung von Joseph Frattaroli
| Salem State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director of Finance/CFO | 2 |
| President | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
| Flagship Consulting, Inc. |
- Börse
- Insiders
- Joseph Frattaroli
- Erfahrung
